Last reviewed · How we verify

Tretinoin Gel Microsphere, 0.1%

Sun Pharmaceutical Industries, Inc. · Phase 1 active Small molecule

Tretinoin Gel Microsphere, 0.1% is a Small molecule drug developed by Sun Pharmaceutical Industries, Inc.. It is currently in Phase 1 development. Also known as: Test Product.

At a glance

Generic nameTretinoin Gel Microsphere, 0.1%
Also known asTest Product
SponsorSun Pharmaceutical Industries, Inc.
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Tretinoin Gel Microsphere, 0.1%

What is Tretinoin Gel Microsphere, 0.1%?

Tretinoin Gel Microsphere, 0.1% is a Small molecule drug developed by Sun Pharmaceutical Industries, Inc..

Who makes Tretinoin Gel Microsphere, 0.1%?

Tretinoin Gel Microsphere, 0.1% is developed by Sun Pharmaceutical Industries, Inc. (see full Sun Pharmaceutical Industries, Inc. pipeline at /company/sun-pharmaceutical-industries-inc).

Is Tretinoin Gel Microsphere, 0.1% also known as anything else?

Tretinoin Gel Microsphere, 0.1% is also known as Test Product.

What development phase is Tretinoin Gel Microsphere, 0.1% in?

Tretinoin Gel Microsphere, 0.1% is in Phase 1.

Related